v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 452,675 $ 467,709
Marketable securities 392,221 396,444
Accounts receivable, net 81,068 73,977
Prepaid expenses and other current assets 69,590 51,870
Inventory, net 8,253 6,742
Total current assets 1,003,807 996,742
Property and equipment, net 12,128 11,462
Operating lease right of use assets, net 37,546 38,783
Other non-current assets 18,614 20,282
Total assets 1,072,095 1,067,269
Current liabilities    
Accounts payable 30,157 24,364
Accrued expenses and other current liabilities 207,388 219,744
Deferred revenue, current 572 583
Operating lease liabilities, current 1,996 2,006
Total current liabilities 240,113 246,697
Deferred revenue, non-current 4,622 4,858
Operating lease liabilities, non-current 40,027 41,556
Interest-bearing loans and borrowings 393,660 393,125
Total liabilities 678,422 686,236
Commitments and contingencies (Note 10)
Shareholders’ equity    
Ordinary shares (voting), £0.002 par value, most recent authority to allot up to a maximum nominal value of £149,633 and shares as of March 31, 2026 and December 31, 2025, respectively, and 50,831,928 and 50,689,271 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively. 137 136
Deferred shares, £0.0001 par value, 5,793,501 shares authorized, issued and outstanding as of March 31, 2026 and December 31, 2025. 1 1
Additional paid-in capital 1,247,212 1,240,255
Accumulated deficit (818,304) (831,275)
Accumulated other comprehensive loss (35,373) (28,084)
Total shareholders' equity 393,673 381,033
Total liabilities and shareholders' equity $ 1,072,095 $ 1,067,269